Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have inflammatory bowel disease (IBD), the majority ulcerative colitis (UC). An inherent problem in interpreting positive findings in genetic association studies of PSC is thus to distinguish between factors associated with hepatobiliary versus intestinal pathology. We aimed to clarify to what extent human leukocyte antigen (HLA) class II associations in UC patients with and without PSC differ. High-resolution DRB1 and DQB1 typing was performed in 365 Scandinavian PSC patients, an independent cohort of 330 Norwegian UC patients and 368 healthy controls. HLA associations found in PSC were mostly distinct from those seen in UC, and no significant differences were noted between PSC patients with concurrent UC and PSC patients without IBD. This suggests different HLA associated genetic susceptibility to PSC and UC, and supports notions that UC in PSC may represent a distinct UC phenotype.

[1]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[2]  E. Schrumpf,et al.  Hepatobiliary Complications of Inflammatory Bowel Disease , 1988, Seminars in liver disease.

[3]  E. Schrumpf,et al.  Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis , 1991, Seminars in liver disease.

[4]  M. Vatn,et al.  Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. , 1996, Scandinavian journal of gastroenterology.

[5]  D. Jewell,et al.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.

[6]  K. Boberg,et al.  HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. , 1999, Tissue antigens.

[7]  P. Reitsma,et al.  HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis , 1999, Gut.

[8]  K. Boberg,et al.  Epidemiology of primary sclerosing cholangitis. , 2001, Best practice & research. Clinical gastroenterology.

[9]  P. Donaldson,et al.  Immunogenetics in PSC. , 2001, Best practice & research. Clinical gastroenterology.

[10]  P. Donaldson,et al.  Evaluation of the Role of MHC Class II Alleles, Haplotypes and Selected Amino Acid Sequences in Primary Sclerosing Cholangitis , 2002, Autoimmunity.

[11]  D. Podolsky,et al.  Inflammatory bowel disease. , 2002, The New England journal of medicine.

[12]  T. Ahmad,et al.  The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. , 2003, Tissue antigens.

[13]  G. Bouma,et al.  The immunological and genetic basis of inflammatory bowel disease , 2003, Nature Reviews Immunology.

[14]  E. Schrumpf,et al.  Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries , 2003, Scandinavian journal of gastroenterology.

[15]  D. Jewell,et al.  The contribution of HLA genes to IBD susceptibility and phenotype. , 2004, Best practice & research. Clinical gastroenterology.

[16]  R. Chapman,et al.  Review article: current management of primary sclerosing cholangitis , 2005, Alimentary pharmacology & therapeutics.

[17]  A. Bergquist,et al.  Increased prevalence of primary sclerosing cholangitis among first-degree relatives. , 2005, Journal of hepatology.

[18]  A. Zinsmeister,et al.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis , 2004, Gut.

[19]  Jack Satsangi,et al.  New genes in inflammatory bowel disease: lessons for complex diseases? , 2006, The Lancet.

[20]  T. Ahmad,et al.  Genetics of inflammatory bowel disease: the role of the HLA complex. , 2006, World journal of gastroenterology.

[21]  T. Karlsen,et al.  Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis , 2007, American Journal of Gastroenterology.